Stay updated on Seladelpar in Primary Biliary Cholangitis Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in Primary Biliary Cholangitis Clinical Trial page.

Latest updates to the Seladelpar in Primary Biliary Cholangitis Clinical Trial page
- Check4 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the study record’s existing 403 error.SummaryDifference1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe study record page displays a 403 Forbidden error, so its trial details are unavailable.SummaryDifference0.6%

- Check39 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating restricted access to the content; the page displays the standard header/footer but no study information is accessible.SummaryDifference20%

- Check60 days agoChange DetectedThe page now shows a new revision tag: Revision: v3.6.6, replacing Revision: v3.6.5. This signals a site release update rather than a change to study details.SummaryDifference0.0%

Stay in the know with updates to Seladelpar in Primary Biliary Cholangitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in Primary Biliary Cholangitis Clinical Trial page.